DiscoverInvent: Life SciencesProcess Analytics: how can analytics accelerate the development and manufacture of cell and gene therapies?
Process Analytics: how can analytics accelerate the development and manufacture of cell and gene therapies?

Process Analytics: how can analytics accelerate the development and manufacture of cell and gene therapies?

Update: 2023-11-07
Share

Description

Throughout this series, we’ve explored different diseases we target, the sorts of cells which are under development as therapies, and how the therapies themselves are manufactured. With all this innovation, we shouldn’t be surprised by the increased focus on the means by which processes and products themselves are characterised. So, do current process analytical tools provide the insights therapy developers need? And how can new technologies be implemented in the fast-moving life sciences field?


To find out, join us on Invent: Life Sciences, a podcast brought to you by technology and product development company TTP.


This Week's Guests

Davide Danovi
Davide Danovi leads the cellular pheotyping department at bit.bio. Bit.bio is an award-winning human synthetic biology enterprise with a mission to code cells for health through applying the principles of computation to biology. In his role at bit.bio, Davide's responsibilities emcompass three key areas. Firstly, Infrastructure and training, overseeing the maintenance of essential instruments, conducts staff training, and establishes data analysis infrastructure for imaging and flow cytometry. Secondly, Cell characterisation, verifying the identities of cells, ensuring the accuracy and reliability of experimental results. And finally, Cell type identification, developing modules to precisely identify specific cell types by screening transcription factors, offering innovative solutions for cell identification.

James Kusena
James Kusena is the Vice President of Operations at MicrofluidX. MicrofluidX is industrialising cell and gene therapy manufacturing through it's latest technology, the Cyto Engine, a unified bioreactor and data platform for cell and gene therapy research, development, and manufacturing. James' career began with a focus on bioprocessing and applications, now as VP of Operations, this focus is now shaping the company's technology to align with industry needs. With demonstrated experience in various sectors of the Cell and Gene therapy industry, including: Process Development, Process Translation, Process Transfer, Research & Development and Commercialisation; James' career reflects a fusion of technical expertise and leadership with a commitment to advancing cell therapy manufacturing industry standards and product quality.

Comments 
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Process Analytics: how can analytics accelerate the development and manufacture of cell and gene therapies?

Process Analytics: how can analytics accelerate the development and manufacture of cell and gene therapies?

TTP plc